The post CIMG Inc. completes $55 million Bitcoin purchase through share sale exchange deal appeared on BitcoinEthereumNews.com. Nasdaq-listed firm CIMG Inc. has confirmed the sale of its 220 common stock shares at $0.25 per share, securing up to $55 million. The proceeds were used to purchase 500 BTC tokens to form the company’s Bitcoin treasury reserve strategy.  The exchange deal follows CIMG’s announcement in Beijing that it will incorporate Bitcoin into its financial portfolio. The company stated that exchanging BTC for equity shows its commitment to building a long-term reserve strategy as part of its corporate treasury.  CIMG expands into Bitcoin treasury strategies with 500 BTC Wang Jianshuang, CIMG CEO, acknowledged that the growing interest in cryptocurrency tokens and, in particular, Bitcoin created new opportunities for traditional businesses to interact with blockchain-based technology.  “The growth and recognition of Bitcoin have revealed opportunities for traditional enterprises to integrate organically with the innovative blockchain system. We aim to pioneer a new era of Bitcoin financial applications and become one of the companies engaged in Bitcoin finance.” –Wang Jianshuang, CIMG CEO Jianshuang added that the company aims to increase its crypto reserve over time and expand partnerships in the AI and cryptocurrency sectors. She highlighted Merlin Chain, a layer two infrastructure designed to improve Bitcoin’s capabilities as a potential avenue for collaboration. Common stock shares were sold as a private placement under Regulation S of the Securities Act of 1993. CIMG noted in its press statement that introducing a Bitcoin treasury forms part of its strategic step to improve its financial position. The healthcare firm added that it remains focused on maintaining growth in its primary business sectors alongside expanding into digital finance. CIMG stock jumped by 3.58% in the premarket but quickly dropped in the open market after the announcement. The stock is down 3.53% today, trading at $0.25, with a day range of $0.25 – $0.29, and 5.4… The post CIMG Inc. completes $55 million Bitcoin purchase through share sale exchange deal appeared on BitcoinEthereumNews.com. Nasdaq-listed firm CIMG Inc. has confirmed the sale of its 220 common stock shares at $0.25 per share, securing up to $55 million. The proceeds were used to purchase 500 BTC tokens to form the company’s Bitcoin treasury reserve strategy.  The exchange deal follows CIMG’s announcement in Beijing that it will incorporate Bitcoin into its financial portfolio. The company stated that exchanging BTC for equity shows its commitment to building a long-term reserve strategy as part of its corporate treasury.  CIMG expands into Bitcoin treasury strategies with 500 BTC Wang Jianshuang, CIMG CEO, acknowledged that the growing interest in cryptocurrency tokens and, in particular, Bitcoin created new opportunities for traditional businesses to interact with blockchain-based technology.  “The growth and recognition of Bitcoin have revealed opportunities for traditional enterprises to integrate organically with the innovative blockchain system. We aim to pioneer a new era of Bitcoin financial applications and become one of the companies engaged in Bitcoin finance.” –Wang Jianshuang, CIMG CEO Jianshuang added that the company aims to increase its crypto reserve over time and expand partnerships in the AI and cryptocurrency sectors. She highlighted Merlin Chain, a layer two infrastructure designed to improve Bitcoin’s capabilities as a potential avenue for collaboration. Common stock shares were sold as a private placement under Regulation S of the Securities Act of 1993. CIMG noted in its press statement that introducing a Bitcoin treasury forms part of its strategic step to improve its financial position. The healthcare firm added that it remains focused on maintaining growth in its primary business sectors alongside expanding into digital finance. CIMG stock jumped by 3.58% in the premarket but quickly dropped in the open market after the announcement. The stock is down 3.53% today, trading at $0.25, with a day range of $0.25 – $0.29, and 5.4…

CIMG Inc. completes $55 million Bitcoin purchase through share sale exchange deal

Nasdaq-listed firm CIMG Inc. has confirmed the sale of its 220 common stock shares at $0.25 per share, securing up to $55 million. The proceeds were used to purchase 500 BTC tokens to form the company’s Bitcoin treasury reserve strategy. 

The exchange deal follows CIMG’s announcement in Beijing that it will incorporate Bitcoin into its financial portfolio. The company stated that exchanging BTC for equity shows its commitment to building a long-term reserve strategy as part of its corporate treasury. 

CIMG expands into Bitcoin treasury strategies with 500 BTC

Wang Jianshuang, CIMG CEO, acknowledged that the growing interest in cryptocurrency tokens and, in particular, Bitcoin created new opportunities for traditional businesses to interact with blockchain-based technology. 

Jianshuang added that the company aims to increase its crypto reserve over time and expand partnerships in the AI and cryptocurrency sectors. She highlighted Merlin Chain, a layer two infrastructure designed to improve Bitcoin’s capabilities as a potential avenue for collaboration.

Common stock shares were sold as a private placement under Regulation S of the Securities Act of 1993. CIMG noted in its press statement that introducing a Bitcoin treasury forms part of its strategic step to improve its financial position. The healthcare firm added that it remains focused on maintaining growth in its primary business sectors alongside expanding into digital finance.

CIMG stock jumped by 3.58% in the premarket but quickly dropped in the open market after the announcement. The stock is down 3.53% today, trading at $0.25, with a day range of $0.25 – $0.29, and 5.4 % up throughout the past week. The stock YTD is down 65.16% with a year range of $0.19 – $3.50, showing a steep decline in company revenue throughout the year. 

Corporate treasuries hold around 1.5 million bitcoins

The Beijing-based firm’s introduction of a Bitcoin treasury strategy aligns with the growing trend of publicly listed companies introducing BTC into their balance sheets. According to CoinGecko, corporate treasuries now hold approximately 1,493,561 BTC tokens valued at $165.3 billion. 

There are 129 public treasuries, with a 7.11% stake in the token’s total supply. U.S.-based Strategy leads the chart with a total accumulation of 636.5k BTC. If listed today, CIMG would rank 64th, just below Jasmine International PCL, with 506 BTC holdings. 

Cryptopolitan reported recently that more than 7,700 Bitcoin tokens were accumulated between August 18 and 24 despite BTC declining in prices from its ATH. MicroStrategy was a notable participant, accumulating 3,081 BTC for $356.9 million. 

Current market conditions show heightened volatility, with Bitcoin’s 24-hour trading volume spiking over 7%  to $72.26 billion and the overall crypto market capitalization dropping by 0.35% to 3.77 trillion today.  

Get seen where it counts. Advertise in Cryptopolitan Research and reach crypto’s sharpest investors and builders.

Source: https://www.cryptopolitan.com/cimg-inc-completes-55-m-btc-purchase/

Market Opportunity
Bitcoin Logo
Bitcoin Price(BTC)
$95,310.62
$95,310.62$95,310.62
-1.51%
USD
Bitcoin (BTC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23